Sources

Sources:

Biosynthesis:http://www.sciencedirect.com/science

Block RI, O'Leary DS, Hichwa RD, Augustinack JC, Boles Ponto LL, Ghoneim MM et al. "Effects of frequent marijuana use on memory-related regional cerebral blood flow." //Pharmacology, Biochemistry and Behavior //  2002 May; **72 ** (1-2):237-5

CAS Number: [|http://www.businessdictionary.com/definition/CAS-number-CAS.] Fernández-ruiz, J.; Romero, J.; Velasco, G.; Tolón, R.M.; Ramos, J.A.; Guzmán, M. (2007), " [|Cannabinoid CB2 receptor: A new target for controlling neural cell survival?]", //Trends in Pharmacological Sciences //  **28 ** <span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; line-height: 19px;"> (1): 39–45 <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14.4pt; line-height: 19px;">Iversen, Leslie L. <span style="font-family: Verdana,Geneva,sans-serif;"> //<span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; line-height: 19px;">The Science of Marijuana // <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14.4pt; line-height: 19px;">. Oxford: Oxford UP, 2000. Print. <span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; line-height: 19px;"> <span style="font-family: Verdana,Geneva,sans-serif; font-size: 110%;"> Field, Jason E, Jende-Tindall,Tracey, Pan, Ming, Ramjit, Navindra J., Souza, Fabio E.S., Tharmanathan, Tharsika. “Synthetic THC-Dronabinol: Synthetic route to dronabinol.” United States Patent application publication 2006. <span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; line-height: 19px;"> <span style="font-family: Verdana,Geneva,sans-serif; font-size: 110%; line-height: 200%;">“Marinol: Official FDA information, Side Effects, and Uses.” 18 November 2009. <http://www.drugs.com/pro/marinol.html>. <span style="font-family: Verdana,Geneva,sans-serif; font-size: 110%; line-height: 19px;">Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G. "Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review." <span style="font-family: Verdana,Geneva,sans-serif; font-size: 110%;"><span style="font-family: Verdana,Geneva,sans-serif;"> <span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; line-height: 19px;">Lancet  // <span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; font-style: normal; line-height: 19px;">. 2007 Jul 28; <span style="font-family: Verdana,Geneva,sans-serif; font-style: normal;">**<span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; line-height: 19px;">370 ** <span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; line-height: 19px;">(9584):319-28

Müller-Vahl,K.R. Schneider,U. Koblenz,A. Jöbges,M. Kolbe,H. Daldrup,T. Emrich,H.M. (2002). "Treatment of Tourette's Syndrome with Δ9-Tetrahydrocannabinol (THC): A Randomized Crossover Trial". <span style="font-family: Verdana,Geneva,sans-serif;"> //<span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; line-height: 19px;">Pharmacopsychiatry //<span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; font-style: normal; line-height: 19px;"> <span style="font-family: Verdana,Geneva,sans-serif; font-style: normal;">**<span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; line-height: 19px;">35 ** // <span style="font-family: Verdana,Geneva,sans-serif; font-size: 110%; line-height: 19px;"> (2): 57–61

Munson AE, Harris LS, Friedman MA, Dewey WL, Carchman RA. [|"Anticancer activity of cannabinoids."]Journal of the National Cancer Institute. September 1975; <span style="font-family: Verdana,Geneva,sans-serif;">**<span style="font-family: Verdana,Geneva,sans-serif; font-size: 110%;">55 ** //<span style="font-family: Verdana,Geneva,sans-serif; font-size: 110%;"> <span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; line-height: 19px;">(3):597-602. Accessed 2007-10-27.

Pertwee RG. “Ligands that target cannabinoid receptors in the brain: from THC to anadamide and beyond.” PubMed.gov. The national Library of Medicine national Institutes of Health.

Ramieraz BG, Blázquez C, Gómez del Pulgar T, Guzmán M, de Ceballos ML (2005). "Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation". <span style="font-family: Verdana,Geneva,sans-serif;"> //<span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; line-height: 19px;">Journal of Neuroscience. //<span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; line-height: 19px;"> <span style="font-family: Verdana,Geneva,sans-serif; font-style: normal;">**<span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; line-height: 19px;">25 ** <span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; line-height: 19px;"> (8): 1904–1

"Tetrahydrocannabinol - Compound Summary." // <span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; line-height: 19px;">Pub Chem Compound //<span style="font-family: Verdana,Geneva,sans-serif; font-size: 120%; line-height: 19px;">. NCBI. Web. <http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=16078>.